RFI - Procurement of commercial end to end solution for Immunocompromised assays
If you would like to reply to this request for information, please fill out the response form by clicking the following link. https://atamis-1928.lightning.force.com/lightning/r/ProSpend__Supplier_Documents_Folder__c/a0uSr0000012DgXIAU/view
Buyer
UK Health Security Agency
Value
Not provided
Published
13 May 2024
Closes
13 May 2024
Procurement details
Source
Contracts Finder
Region
Tower Hamlets
Procurement method
Not provided
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
38951000
Real-time Polymerase Chain Reaction (PCR) equipment
Lots
Lot default RFI - Procurement of commercial end to end solution for Immunocompromised assays
Value not provided
If you would like to reply to this request for information, please fill out the response form by clicking the following link. https://atamis-1928.lightning.force.com/lightning/r/ProSpend__Supplier_Documents_Folder__c/a0uSr0000012DgXIAU/view
Delivery: England · United Kingdom, England, United Kingdom
Documents
Unlock document linkEarly engagement notice on Contracts Finder
13 May 2024
Early engagement notice on Contracts Finder
Market engagement notice · Web page
RFI- End to end molecular solution for Immunocompromised assays to include Parvovirus HEV CMV and Entero targets
Not provided
RFI- End to end molecular solution for Immunocompromised assays to include Parvovirus HEV CMV and Entero targets
Contains public sector information licensed under the Open Government Licence v3.0.